Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03691350 · ClinicalTrials.gov registry record · Early Phase 1
Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs
A Early Phase 1 study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 66
- Enrollment target
NCT03691350 is a Early Phase 1 study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 66 participants.
The verdict
NCT03691350, a Early Phase 1 study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 66 participants
- Enrollment target
Study Summary
This trial studies biomarkers obtained by bronchoscopy (bronchoalveolar lavage and lung brushings) to determine the effect of smoking e-cigarettes on the lungs. Studying samples of lung cells from participants who smoke e-cigarettes may help doctors learn more about changes that occur in deoxyribonucleic acid and identify biomarkers related to cancer.
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Bronchoscopy with Bronchoalveolar Lavage
- DRUG Cigarette
- OTHER Electronic Cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2018-09-17 |
| Est. Completion | 2024-03-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03691350
The ClinicalTrials.gov registry entry for NCT03691350 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03691350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03691350 about?
NCT03691350 is a clinical study titled "Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs". This trial studies biomarkers obtained by bronchoscopy (bronchoalveolar lavage and lung brushings) to determine the effect of smoking e-cigarettes on the lungs. Studying samples of lung cells from participants who smoke e-cigarettes may help doctors learn more about changes that occur in deoxyribonu...
What is the current status of trial NCT03691350?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 66 participants. The study started on 2018-09-17. Estimated completion is 2024-03-10.
What interventions are being tested in trial NCT03691350?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Bronchoscopy with Bronchoalveolar Lavage (PROCEDURE), Cigarette (DRUG), Electronic Cigarette (OTHER).
Who is sponsoring clinical trial NCT03691350?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.